Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Arbutus Biopharma Corp ABUS

Healthcare Biotechnology
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ABUS)

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire 8 days ago

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna

GlobeNewswire April 4, 2024

Arbutus to Participate in Two Upcoming Investor Conferences

GlobeNewswire March 8, 2024

Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

GlobeNewswire February 29, 2024

Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update

GlobeNewswire February 15, 2024

Arbutus Announces 2024 Corporate Objectives and Provides Financial Update

GlobeNewswire January 8, 2024

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

GlobeNewswire November 9, 2023

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

GlobeNewswire November 9, 2023

Arbutus to Present at Jefferies London Healthcare Conference

GlobeNewswire November 8, 2023
View More News ››

Opinion & Analysis (NDAQ:ABUS)

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Streetwise Reports May 20, 2020

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra October 15, 2014

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014
View More Opinion ››

Bullboard Posts (NDAQ:ABUS)

Time to put this puppy on the block....

Qilu or Moderna sound good.
hoffbag - January 11, 2022

Action these days!

Two big news stories at the same time - the win of an appeal on the patent challenge to Moderna and promising early results on the cHVB...
slithey - December 6, 2021

TKM

https://www.ctvnews.ca/health/coronavirus/how-the-early-work-of-a-canadian-scientist-and-his-team-made-the-covid-19-vaccines-possible-1...
zutfie - September 27, 2021

RE:Sleepy, quiet low float

Still sleepy and quiet....
hoffbag - April 2, 2021

RE:ABUS

Wow, another good news.
BelilieThun - July 26, 2020

ABUS

ABUS seems to win patent litigation fight with covid-19 vaccine implications.
RaselVio - July 26, 2020
View more Bullboard ››

Heritage Mining Ltd.

Heritage Mining Ltd.

Heritage Mining Ltd. is focused on acquiring and developing Tier-1 advanced stage precious and base metal exploration ...
View More »